Shirin Attarian

Shirin Attarian, MD is an Assistant Professor in the Division of Hematology and Oncology at the University of California, Irvine School of Medicine. Her research focuses on improving diagnostic procedures in hematopathology, optimizing immune checkpoint inhibitor therapy outcomes, and understanding metabolic complications in hematological malignancies.

• Research Interests: Bone marrow biopsy techniques, cancer immunotherapy, hypercalcemia mechanisms, vitamin D metabolism
• Clinical Focus: Hematology-Oncology, inpatient cancer care, endocrine complications of malignancies

Publication Trends show her work spans:

• Bone marrow biopsy methodology (2014, 2018)
• Immune checkpoint inhibitor clinical outcomes (2021)
• Calcium metabolism in lymphoma (1996)
• Endocrine effects of somatostatin analogs (1993)

Her scholarship bridges Hematology, Oncology, and Endocrinology, with emphasis on procedural optimization and metabolic complications of cancer therapies.